BioTek Instruments has named Danny Luo as the new general manager of its China office.
BioTek Instruments has named Danny Luo as the new general manager of its China office. In a statement announcing Luo’s appointment, the company said that he is expected to grow and maintain the brand and revenues in the Chinese market, as well as spending his time liaising with the senior management to execute the company’s strategic plan, identify market requirements and emerging trends and optimize product and service levels in the Chinese market.
In the statement, Steven Fisher, managing director of the company’s Singapore branch said, "China is BioTek’s fastest growing and evolving market, and we needed a dynamic and market-proven leader to capitalize on this opportunity. Danny Luo’s excellent performance over the past few years made him the obvious choice for the position."
According to the company, Luo joined in 2006 as the marketing manager for China and Hong Kong, where he had responsibility for the local marketing and brand development. Since then he has also played a role in developing the company’s market presence in China and Hong Kong by introducing specialized collateral materials, actively driving channel development, and creating ongoing training and support systems for customers and distributors.
More information about the company is available at www.biotek.com or visit the Chinese website at www.biotekchina.com.cn
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Investigating Synthetic Cathinone Positional Isomers using LC–EAD-MS
November 7th 2024Peng Che fom Vrije Universiteit Amsterdam in the Netherlands discusses the benefits of hyphenating liquid chromatography (LC) with electron activated dissociation mass spectrometry (EAD-MS) to analyze cathinone positional isomers.